Ascentage Pharma Group International (AAPG) Actionnariat — Transactions d'Initiés et Politiques
Ascentage Pharma Group International (AAPG) — Prix $15.40 Healthcare — Biotechnology — NASDAQ
Données de Financial Modeling Prep · mis à jour le 16 septembre 2026 · cours différés de 15 min
Derniers résultats publiés: 9 septembre 2026
Actionnariat et activité des initiés pour Ascentage Pharma Group International (AAPG): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
Prix $15.40 Capitalisation $1.4B Bourse NASDAQ Pays CN
Transactions d'Initiés Récentes Date Initié Type Actions Valeur 2026-06-25 Miyara Faical 2026-05-21 Zhai Yifan M-Exempt 95,575 2026-05-21 Zhai Yifan M-Exempt 92,746 2026-05-20 Zhai Yifan A-Award 298,195 2026-05-20 Zhai Yifan A-Award 298,194 $2.0M 2026-05-20 Zhai Yifan A-Award 214,999 2026-05-20 Zhai Yifan A-Award 214,988 $1.4M 2026-05-20 Zhai Yifan A-Award 103,365 2026-05-20 Zhai Yifan A-Award 103,364 $839K 2026-05-20 Zhai Yifan A-Award 95,575
Bilan (10 ans) Année 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trésorerie $294.5M $14.8M $957.1M $878.5M $1.02B $1.71B $1.48B $1.07B $1.24B $2.47B Placements à Court Terme $157.4M $384.2M $14.4M 0 0 0 0 0 0 0 Créances $8.3M $7.9M $5.3M $2.5M $480000 $54.1M $61.5M $163.5M $99.1M $253.1M Stocks 0 0 0 0 0 $3.9M $9.4M $16.2M $6.6M $28.6M Actifs Courants $463.7M $414.7M $990.2M $909.1M $1.08B $1.89B $1.64B $1.34B $1.47B $2.95B Immobilisations Corporelles $4.5M $25.3M $34.0M $110.2M $477.0M $854.3M $650.0M $957.2M $905.9M $829.6M Goodwill $24.7M $24.7M $24.7M $24.7M $24.7M $24.7M $24.7M $24.7M $24.7M $24.7M Actifs Incorporels $87.1M $80.7M $108.5M $104.3M $97.4M $60.4M $84.3M $85.4M $76.0M $66.0M Actifs Totaux $593.3M $581.7M $1.23B $1.21B $1.73B $2.94B $2.83B $2.50B $2.62B $3.97B Dettes Fournisseurs $156000 $3.8M $5.1M $13.1M $23.4M $70.9M $95.6M $72.4M $92.0M $106.8M Dette à Court Terme 0 0 $35.0M $85.0M $44.8M $39.8M $510.3M $606.6M $769.6M $1.22B Passifs Courants $77.6M $79.5M $105.3M $202.1M $276.1M $361.1M $881.2M $934.2M $1.17B $1.64B Dette à Long Terme 0 0 0 0 $473.1M $1.03B $1.27B $1.17B $868.6M $742.8M Passifs Totaux $607.9M $713.5M $2.24B $314.6M $884.4M $1.71B $2.42B $2.43B $2.34B $2.63B Réserves -$152.0M -$270.5M -$615.8M -$2.10B -$2.77B -$3.56B -$4.44B -$5.37B -$5.77B 0 Capitaux Propres -$14.6M -$131.8M -$1.01B $890.5M $846.6M $1.23B $408.7M $60.4M $264.2M $1.33B Dette Totale $830000 $4.9M $42.0M $101.4M $529.7M $1.08B $1.79B $1.80B $1.67B $1.98B Dette Nette -$451.1M -$394.1M -$929.4M -$777.1M -$490.3M -$622.6M $317.1M $726.3M $431.9M -$490.7M Fonds de Roulement $386.1M $335.2M $885.0M $707.0M $802.9M $1.52B $755.3M $410.0M $307.6M $1.30B
Santé financière
Dette / Capitaux propres 3.76 Ratio de liquidité 1.22
Rentabilité
Rentabilité des capitaux propres -153.85% Rentabilité du capital investi -48.88% Rentabilité des actifs -44.65% Marge brute 81.56% Marge opérationnelle -218.76% Marge nette -228.69%